Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Amdocs expects Revenue for 2025 FY is expected to down by (10.9)% - (9.1)% YoY; Non-GAAP Diluted earnings per share is expected to up by 6.5%-10.5%YoY.

Author: Benzinga Newsdesk | May 07, 2025 04:27pm

Amdocs (NASDAQ:DOX) .

Posted In: DOX